Redirecting adenoviruses to tumour cells using therapeutic antibodies: generation of a versatile human bispecific adaptor
Effective use of adenovirus-5 (Ad5) in cancer therapy is heavily dependent on the degree to which the virus's natural tropism can be subverted to one that favours tumour cells. This is normally achieved through either engineering of the viral fiber knob or the use of bispecific adaptors that di...
Hlavní autoři: | , , , , , , , , , |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2015
|